Free Trial

What is DA Davidson's Estimate for NICE Q2 Earnings?

NICE logo with Computer and Technology background

NICE Ltd. (NASDAQ:NICE - Free Report) - Analysts at DA Davidson issued their Q2 2025 EPS estimates for NICE in a note issued to investors on Friday, May 16th. DA Davidson analyst G. Luria anticipates that the technology company will post earnings per share of $2.43 for the quarter. DA Davidson currently has a "Buy" rating and a $185.00 target price on the stock. The consensus estimate for NICE's current full-year earnings is $9.85 per share.

A number of other equities research analysts have also recently issued reports on NICE. Cantor Fitzgerald reiterated a "neutral" rating and issued a $161.00 target price on shares of NICE in a research note on Friday. Morgan Stanley cut their price objective on shares of NICE from $235.00 to $202.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Barclays cut their price objective on shares of NICE from $286.00 to $226.00 and set an "overweight" rating on the stock in a research note on Friday, February 21st. Rosenblatt Securities lifted their price objective on shares of NICE from $180.00 to $190.00 and gave the company a "buy" rating in a research note on Friday. Finally, Royal Bank of Canada restated an "outperform" rating and set a $200.00 price objective on shares of NICE in a research note on Friday. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, NICE has a consensus rating of "Moderate Buy" and an average target price of $212.92.

View Our Latest Research Report on NICE

NICE Stock Performance

NICE stock opened at $163.43 on Monday. The stock has a market capitalization of $10.34 billion, a price-to-earnings ratio of 24.18, a PEG ratio of 1.07 and a beta of 1.03. NICE has a 1 year low of $137.19 and a 1 year high of $202.36. The stock's fifty day moving average is $153.97 and its two-hundred day moving average is $165.10.

NICE (NASDAQ:NICE - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The technology company reported $2.25 EPS for the quarter, missing analysts' consensus estimates of $2.96 by ($0.71). The business had revenue of $721.60 million during the quarter, compared to analyst estimates of $718.47 million. NICE had a return on equity of 16.17% and a net margin of 16.18%.

Institutional Investors Weigh In On NICE

Hedge funds and other institutional investors have recently bought and sold shares of the business. Sanctuary Advisors LLC raised its position in NICE by 329.9% in the fourth quarter. Sanctuary Advisors LLC now owns 5,743 shares of the technology company's stock worth $948,000 after acquiring an additional 4,407 shares in the last quarter. Clear Creek Financial Management LLC raised its position in NICE by 106.5% in the fourth quarter. Clear Creek Financial Management LLC now owns 4,303 shares of the technology company's stock worth $731,000 after acquiring an additional 2,219 shares in the last quarter. Ceera Investments LLC bought a new stake in NICE in the fourth quarter worth about $4,963,000. Haven Capital Group Inc. purchased a new position in NICE in the 4th quarter worth about $5,577,000. Finally, Level Wealth Management LLC purchased a new position in NICE in the 4th quarter worth about $487,000. 63.34% of the stock is currently owned by institutional investors.

NICE Company Profile

(Get Free Report)

NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NICE Right Now?

Before you consider NICE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NICE wasn't on the list.

While NICE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines